Glucocorticoid Reduction in Different Profiles of Patients with Rheumatoid Arthritis and Treatment with Sarilumab

被引:0
|
作者
Rubio Romero, Esteban [1 ]
Munoz Jimenez, Alejandro [2 ]
Martinez Perez, Rosalia [1 ]
Mendez Diaz, Lara [3 ]
机构
[1] Virgen del Rocio Univ Hosp, Seville, Spain
[2] Hosp Univ Virgen del Rocio Sevilla, Seville, Spain
[3] Virgen del Rocio Hosp, Seville, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1224
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Sarilumab for the treatment of rheumatoid arthritis
    Cooper, Simon
    IMMUNOTHERAPY, 2016, 8 (03) : 249 - 250
  • [2] A review of sarilumab for the treatment of rheumatoid arthritis
    Lee, Eun Bong
    IMMUNOTHERAPY, 2018, 10 (01) : 57 - 65
  • [3] Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis
    Christine Xu
    Yaming Su
    Anne Paccaly
    Vanaja Kanamaluru
    Clinical Pharmacokinetics, 2019, 58 : 1455 - 1467
  • [4] Population Pharmacokinetics of Sarilumab in Patients With Rheumatoid Arthritis
    Xu, Christine
    Su, Yaming
    Paccaly, Anne
    Kanamaluru, Vanaja
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S20 - S20
  • [5] Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis
    Xu, Christine
    Su, Yaming
    Paccaly, Anne
    Kanamaluru, Vanaja
    CLINICAL PHARMACOKINETICS, 2019, 58 (11) : 1455 - 1467
  • [6] Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment
    Lazzerini, PE
    Capecchi, PL
    Bisogno, S
    Galeazzi, M
    Marcolongo, R
    Pasini, FL
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (07) : 694 - 695
  • [7] Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Buch, Maya H.
    Tanaka, Yoshiya
    Kameda, Hideto
    Praestgaard, Amy
    van Hoogstraten, Hubert
    Fernandez-Nebro, Antonio
    Huizinga, Thomas
    RHEUMATOLOGY, 2022, 61 (06) : 2596 - 2602
  • [8] Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
    Raimondo, Maria Gabriella
    Biggioggero, Martina
    Crotti, Chiara
    Becciolini, Andrea
    Favalli, Ennio Giulio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1593 - 1603
  • [9] SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RHEUMATOID ARTHRITIS PATIENTS
    Genovese, Mark C.
    Fay, Jon
    Parrino, Janie
    Beyer, Doris
    Iglesias-Rodriguez, Melitza
    Graham, Neil
    Boddy, Alex
    Martincova, Renata
    Burmester, Gerd R.
    RHEUMATOLOGY, 2017, 56 : 139 - 139
  • [10] EFFICACY OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO PREVIOUSLY RECEIVED SARILUMAB OR TOCILIZUMAB
    Emery, Paul
    van Hoogstraten, Hubert
    Jayawardena, Shyamalie
    Mangan, Erin
    Cejas, Paula
    Verschueren, Patrick
    RHEUMATOLOGY, 2018, 57